Clinical Trials · NCT03375788
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 51
- Start date
- Jan 2019
- Locations
- 1 site, United States
- Primary endpoint
- Liver Fat Content